Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

RAD001 – Anti-Cancer Therapy, Anti-neoplastic agent by Novartis

When the tumour is confined to the kidney, renal cell cancer may be asymptomatic. When symptoms are present they typically include blood in the urine (haematuria), flank pain and a palpable abdominal mass. Afinitor was approved for the treatment of renal cell cancer in 2009.

  • Cross-section of a solid tumour
  • Renal cell carcinoma (RCC)
  • Common secondary sites of RCC

Go Top